MedPath

A study to check the salivary and tissue levels of Chemerin and tissue CD34 for early detection and follow up of Oral Cancer patients

Not Applicable
Conditions
Health Condition 1: D000- Carcinoma in situ of lip, oral cavity and pharynxHealth Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
Registration Number
CTRI/2023/11/059680
Lead Sponsor
Pavithra V
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

For Tissues

Group 1 Well Diffrentiated Oral Squamous Cell Carcinoma

Group2 Moderate and Poorly Diffrentiated Oral Squamous Cell Carcinoma

For Saliva

Group 1 Well,Moderate,Poorly differentiated and recurrent cases of Oral Squamous Cell Carcinoma

Group 2 Premalignant lesions showing moderate and severe dysplasia

Group 3 Clinically healthy individuals without any systemic diseases

Exclusion Criteria

Patients with systemic diseases, inflammatory oral lesions, periodontal disease, Prior history of other malignancy, Prior treatment in the form of chemotherapy, radiotherapy, Pregnancy, Lactating mothers, Patients who are obese (BMI =30).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath